{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Indiana",
      "state": "PA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "82532",
      "recalling_firm": "RemedyRepack Inc.",
      "address_1": "625 Kolter Dr Ste 4",
      "address_2": "N/A",
      "postal_code": "15701-3571",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed to one sole customer, Miami, FL.",
      "recall_number": "D-1081-2019",
      "product_description": "Losartan 50mg Tablet, 30 count each blister card.",
      "product_quantity": "33 blister cards of 30 = 990 tablets",
      "reason_for_recall": "CGMP Deviations; Detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) - N-Methylnitrosobutyric acid (NMBA).",
      "recall_initiation_date": "20190314",
      "center_classification_date": "20190405",
      "termination_date": "20190411",
      "report_date": "20190417",
      "code_info": "70518-0588-01, Lot #: J0328416-101518, Exp. Date: 10/2019"
    }
  ]
}